Sponsor study identifier
observational
1,315
1 country
4
Study Start
September 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2019
Actual (reported)Study Completion
December 2020
Actual (reported)Retrospective and prospective cohort of patients with germ cell tumor in treatment.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2020
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 7, 2016
Actual (reported)August 11, 2016
Actual (reported)September 2016
Date type not reportedThis date has not been verified as actual or estimated.
December 2019
Actual (reported)December 2020
Actual (reported)Brazilian multicenter database in order to collect and analyze data from diagnosis and treatment of patients with germ cell tumor
From 2000 to 2025
Description of demographic characteristics of testicular germ cell tumor patients in Brazil
From 2000 to 2025
The clinical and pathological characteristics of testicular germ cell tumor patients in Brazil.
From 2000 to 2025
Treatment according to staging and relapse of patients diagnosed with testicular germ cell tumor in Brazil
From 2000 to 2025
Disease free survival of patients diagnosed with germ cell tumor stage 1.
From 2000 to 2025
Overall survival of patients diagnosed with germ cell tumor stage 1.
From 2000 to 2025
Men with diagnosis of testicular, retroperitonium or mediastinal primary tumor.
CPO - Pucrs
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Israelita Albert Einstein
São Paulo, Brazil
Hospital São José
São Paulo, Brazil
ICESP
São Paulo, Brazil
Gustavo Werutsky, MD
Latin American Cooperative Oncology Group
Diogo Bastos, MD
Instituto do Cancer do Estado de São Paulo
1,315 participants (actual enrollment reported by the registry).
First Submitted
July 7, 2016
First Posted
August 11, 2016
Study Start
September 2016
Date type not reportedThis date has not been verified as actual or estimated.
Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy
Contact the study team to confirm eligibility.
Primary Completion
December 2019
Actual (reported)Study Completion
December 2020
Actual (reported)Last Updated
December 27, 2021
Record last verified: 2021-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: